Learning Objectives
Upon completion of this activity, participants should be able to:
Discuss appropriate management of a nonelderly patient with metastatic hormone- refractory prostate cancer.
Describe the role of chemotherapy as primary therapy for metastatic hormone-refractory prostate cancer.
Evaluate treatment alternatives depending on patient risk factors.
Evaluate the first- and second-line treatment options for a younger patient with metastatic hormone refractory prostate cancer and significant comorbidities.